545 related articles for article (PubMed ID: 33847047)
1. Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics.
Jering KS; Claggett B; Pfeffer MA; Granger C; Køber L; Lewis EF; Maggioni AP; Mann D; McMurray JJV; Rouleau JL; Solomon SD; Steg PG; van der Meer P; Wernsing M; Carter K; Guo W; Zhou Y; Lefkowitz M; Gong J; Wang Y; Merkely B; Macin SM; Shah U; Nicolau JC; Braunwald E
Eur J Heart Fail; 2021 Jun; 23(6):1040-1048. PubMed ID: 33847047
[TBL] [Abstract][Full Text] [Related]
2. Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy.
Shah AM; Claggett B; Prasad N; Li G; Volquez M; Jering K; Cikes M; Kovacs A; Mullens W; Nicolau JC; Køber L; van der Meer P; Jhund PS; Ibram G; Lefkowitz M; Zhou Y; Solomon SD; Pfeffer MA
Circulation; 2022 Oct; 146(14):1067-1081. PubMed ID: 36082663
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial.
Mehran R; Steg PG; Pfeffer MA; Jering K; Claggett B; Lewis EF; Granger C; Køber L; Maggioni A; Mann DL; McMurray JJV; Rouleau JL; Solomon SD; Ducrocq G; Berwanger O; De Pasquale CG; Landmesser U; Petrie M; Leng DSK; van der Meer P; Lefkowitz M; Zhou Y; Braunwald E
Circulation; 2022 Dec; 146(23):1749-1757. PubMed ID: 36321459
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI.
Mann DL; Nicolas J; Claggett B; Miao ZM; Granger CB; Kerkar P; Køber L; Lewis EF; McMurray JJV; Maggioni AP; Núñez J; Ntsekhe M; Rouleau JL; Sim D; Solomon SD; Steg PG; van der Meer P; Braunwald E; Pfeffer MA; Mehran R
J Am Coll Cardiol; 2024 Mar; 83(9):904-914. PubMed ID: 38418004
[TBL] [Abstract][Full Text] [Related]
5. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
[TBL] [Abstract][Full Text] [Related]
6. Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial.
Schou M; Claggett B; Miao ZM; Fernandez A; Filippatos G; Granger C; Jering K; Maggioni AP; McCausland F; Villota JN; Rouleau JL; Mody FV; van der Meer P; Vinereanu D; McGrath M; Zhou Y; Mann DL; Solomon SD; Steg PG; Braunwald E; McMurray JJV; Pfeffer MA; Køber L
Eur J Heart Fail; 2024 Jan; 26(1):130-139. PubMed ID: 37933184
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
Pfeffer MA; Claggett B; Lewis EF; Granger CB; Køber L; Maggioni AP; Mann DL; McMurray JJV; Rouleau JL; Solomon SD; Steg PG; Berwanger O; Cikes M; De Pasquale CG; East C; Fernandez A; Jering K; Landmesser U; Mehran R; Merkely B; Vaghaiwalla Mody F; Petrie MC; Petrov I; Schou M; Senni M; Sim D; van der Meer P; Lefkowitz M; Zhou Y; Gong J; Braunwald E;
N Engl J Med; 2021 Nov; 385(20):1845-1855. PubMed ID: 34758252
[TBL] [Abstract][Full Text] [Related]
8. Impact of sacubitril/valsartan on cardiac arrest event rate. Letter regarding the article 'Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics'.
El-Battrawy I; Akin I
Eur J Heart Fail; 2022 Jul; 24(7):1324. PubMed ID: 35118775
[No Abstract] [Full Text] [Related]
9. Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win-ratio analysis of the PARADISE-MI trial.
Berwanger O; Pfeffer M; Claggett B; Jering KS; Maggioni AP; Steg PG; Mehran R; Lewis EF; Zhou Y; van der Meer P; De Pasquale C; Merkely B; Filippatos G; McMurray JJV; Granger CB; Solomon SD; Braunwald E
Eur J Heart Fail; 2022 Oct; 24(10):1918-1927. PubMed ID: 36054480
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Efficacy and Safety of Sacubitril/Valsartan versus Ramipril in Patients With ST-Segment Elevation Myocardial Infarction.
Rezq A; Saad M; El Nozahi M
Am J Cardiol; 2021 Mar; 143():7-13. PubMed ID: 33417876
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial.
Jering KS; Claggett BL; Pfeffer MA; Granger CB; Køber L; Lewis EF; Maggioni AP; Mann DL; McMurray JJV; Prescott MF; Rouleau JL; Solomon SD; Steg PG; von Lewinski D; Braunwald E
Circ Heart Fail; 2023 May; 16(5):e010259. PubMed ID: 37125529
[TBL] [Abstract][Full Text] [Related]
12. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
Srivastava PK; Claggett BL; Solomon SD; McMurray JJV; Packer M; Zile MR; Desai AS; Rouleau JL; Swedberg K; Fonarow GC
JAMA Cardiol; 2018 Dec; 3(12):1226-1231. PubMed ID: 30484837
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction.
Tan NY; Sangaralingham LR; Sangaralingham SJ; Yao X; Shah ND; Dunlay SM
JACC Heart Fail; 2020 Jan; 8(1):43-54. PubMed ID: 31838035
[TBL] [Abstract][Full Text] [Related]
14. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.
Solomon SD; Vaduganathan M; L Claggett B; Packer M; Zile M; Swedberg K; Rouleau J; A Pfeffer M; Desai A; Lund LH; Kober L; Anand I; Sweitzer N; Linssen G; Merkely B; Luis Arango J; Vinereanu D; Chen CH; Senni M; Sibulo A; Boytsov S; Shi V; Rizkala A; Lefkowitz M; McMurray JJV
Circulation; 2020 Feb; 141(5):352-361. PubMed ID: 31736342
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF.
Jering KS; Zannad F; Claggett B; Mc Causland FR; Ferreira JP; Desai A; Barkoudah E; McMurray JJV; Pfeffer MA; Solomon SD
JACC Heart Fail; 2021 Jan; 9(1):13-24. PubMed ID: 33189633
[TBL] [Abstract][Full Text] [Related]
16. [Angiotensine Receptor-Neprilysin Inhibitor combination is not the preferred medication for patients after acute myocardial infarction].
Kok W
Ned Tijdschr Geneeskd; 2022 May; 166():. PubMed ID: 35736368
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin Receptor-Neprilysin Inhibitor in Acute Myocardial Infarction.
Pathak P
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443387
[TBL] [Abstract][Full Text] [Related]
18. The initial timing and dosage pattern of sacubitril/valsartan in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Gu J; Wang Y; Wang CQ; Zhang JF
Eur J Intern Med; 2023 Jun; 112():62-69. PubMed ID: 36990878
[TBL] [Abstract][Full Text] [Related]
19. Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.
Vaduganathan M; Mentz RJ; Claggett BL; Miao ZM; Kulac IJ; Ward JH; Hernandez AF; Morrow DA; Starling RC; Velazquez EJ; Williamson KM; Desai AS; Zieroth S; Lefkowitz M; McMurray JJV; Braunwald E; Solomon SD
Eur Heart J; 2023 Aug; 44(31):2982-2993. PubMed ID: 37210743
[TBL] [Abstract][Full Text] [Related]
20. Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy.
Okumura N; Jhund PS; Gong J; Lefkowitz MP; Rizkala AR; Rouleau JL; Shi VC; Swedberg K; Zile MR; Solomon SD; Packer M; McMurray JJ;
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27618854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
